Core Viewpoint - The company reported a significant increase in revenue and net profit for the fiscal year 2025, indicating strong growth and market positioning in the medical imaging and healthcare equipment sector [1]. Financial Performance - The company achieved total operating revenue of 13.821 billion yuan, representing a year-on-year growth of 34.18% [1]. - The net profit attributable to the parent company was 1.888 billion yuan, reflecting a year-on-year increase of 49.60% [1]. Market Position and Strategy - The company is focusing on building long-term competitiveness through systematic innovation in product introduction, deepening global market layout, optimizing supply chain systems, and accumulating core technological capabilities [1]. - The demand for high-end medical imaging, radiotherapy, and grassroots diagnostic equipment is continuously being released, particularly as China's large-scale medical equipment update policy enters a normalized and specialized implementation phase in 2025 [1]. - The company has been increasing its market share domestically and maintaining its leading position in the industry, with significant growth in revenue scale and enhanced operational quality and profitability [1].
联影医疗2025年度归母净利润18.88亿元 同比增长49.60%